
On Thursday Adobe announces it has partnered with chip supplier Qualcomm to expand its marketing cloud offerings.
The partnership will see Adobe integrate its Adobe Experience Cloud with Qualcomm’s Snapdragon Digital Experience Platform, enabling marketers to create more personalized and engaging experiences for customers across a range of devices.
The collaboration also advances Qualcomm’s use of Adobe Creative Cloud and Adobe Document Cloud applications, ensuring content and services are delivered to the most relevant audiences.
Read more: Qualcomm Loses Bid To End Chip Antitrust Case
“Whether a customer is buying a connected device or the cutting-edge chips inside, everyone now expects to have a brand experience that is captivating, connected and relevant,” said Don McGuire, senior vice president and chief marketing officer of Qualcomm Technologies, Inc. “Adobe Experience Platform empowers us to reimagine the way we engage customers when they embrace our transformative technologies by integrating real-time personalization into our omnichannel approach.”
“By adopting Adobe’s enterprise applications, Qualcomm has an end-to-end solution that will enhance omnichannel experiences for business customers and improve marketing performance,” said Anil Chakravarthy, president, digital experience business of Adobe. “The partnership will help Qualcomm take its own digital transformation to the next level and deliver new ways to showcase the transformative technologies it is delivering to the world.”
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas